Quintiles Transnational Holdings Inc (Q) : Gareth Morgan Investments Limited Partnership scooped up 142,440 additional shares in Quintiles Transnational Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 202,630 shares of Quintiles Transnational Holdings Inc which is valued at $15,480,932.Quintiles Transnational Holdings Inc makes up approximately 1.45% of Gareth Morgan Investments Limited Partnership’s portfolio.
Other Hedge Funds, Including , Engineers Gate Manager Lp sold out all of its stake in Q during the most recent quarter. The investment firm sold 78,541 shares of Q which is valued $6,000,532.Blackrock Institutional Trust Company N.a. reduced its stake in Q by selling 95,617 shares or 3.77% in the most recent quarter. The Hedge Fund company now holds 2,439,447 shares of Q which is valued at $186,373,751. Quintiles Transnational Holdings Inc makes up approx 0.03% of Blackrock Institutional Trust Company N.a.’s portfolio.Ubs Asset Management Americas Inc boosted its stake in Q in the latest quarter, The investment management firm added 44,887 additional shares and now holds a total of 244,613 shares of Quintiles Transnational Holdings Inc which is valued at $18,774,048. Quintiles Transnational Holdings Inc makes up approx 0.02% of Ubs Asset Management Americas Inc’s portfolio.Tillar-wenstrup Advisors boosted its stake in Q in the latest quarter, The investment management firm added 5,470 additional shares and now holds a total of 19,117 shares of Quintiles Transnational Holdings Inc which is valued at $1,433,775. Quintiles Transnational Holdings Inc makes up approx 1.36% of Tillar-wenstrup Advisors’s portfolio. Kanaly Trust Co added Q to its portfolio by purchasing 66 company shares during the most recent quarter which is valued at $4,886.
Quintiles Transnational Holdings Inc closed down -0.58 points or -0.76% at $76.01 with 7,23,382 shares getting traded on Tuesday. Post opening the session at $76.84, the shares hit an intraday low of $75.95 and an intraday high of $76.96 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Quintiles Transnational Holdings Inc reported $0.93 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.90. The company had revenue of $1167.10 million for the quarter, compared to analysts expectations of $1150.61 million. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.78 EPS.
Many Wall Street Analysts have commented on Quintiles Transnational Holdings Inc. Quintiles Transnational Holdings Inc was Upgraded by Avondale to ” Mkt Outperform” on Jul 12, 2016.
Quintiles Transnational Holdings Inc. is a biopharmaceutical services company. The Company is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. It also offers therapeutic scientific and analytical services to its biopharmaceutical and other healthcare customers. The Company offers its services through two segments: Product Development and Integrated Healthcare Services. Its product development segment is a contract research organization (CRO) and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. Its Integrated Healthcare Services segment provides services including commercial services such as contract pharmaceutical sales forces and healthcare business services such as phase research market access and consulting and health information analytics and technology consulting.